Back

Icosapent Ethyl, a new player in reducing atherothrombotic risk?

20 October 2022 (18:52 - 19:15)
Organised by: Logo
Seminar Presentation Part of: One step further in reducing established cardiovascular disease risk: targeting atherothrombosis after REDUCE-IT Thrombosis, Bleeding Open Access EuroThrombosis and EuroVessels 2022 WG on Thrombosis

About the speaker

Photo
Professor Victor Aboyans

The Princess Grace Hospital Centre, Monaco (Monaco)

1 More presentation in this session

Presentation thumbnail
Established CVD and atherothrombosis: how did we get here and how can we get out
Doctor F. Araujo (Lisbon, PT)

Access the full session

Session thumbnail
One step further in reducing established cardiovascular disease risk: targeting atherothrombosis after REDUCE-IT

The Event

Event poster

EuroThrombosis and EuroVessels 2022

20 October 2022 18:52 CET
You may be interested in
thumbnail
Congress Session
New frontiers in ASCVD risk reduction: integrating icosapent ethyl in clinical practice
26 August 2022
thumbnail
Congress Presentation
Cost-effectiveness of icosapent ethyl for primary and secondary cardiovascular prevention in the UK
27 August 2022
thumbnail
Congress Presentation
Introduction
27 August 2023
thumbnail
Congress Presentation
Cross-sectional analysis of demographic and clinical characteristics of patients using icosapent ethyl
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources